2024-11-20 15:28:28
Kazia Calls for Increased Focus on Brain Cancer Research this GBM Awareness Day
Corporate/ 2023-07-23
Kazia Calls for Increased Focus on Brain...

SYDNEY,July 21,2021-- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA),a leading drug development company in the field of brain cancer,to...

China NMPA Approves Phase III Clinical Trial of ASC40 Combined with Bevacizumab for Treatment of Patients with Recurrent Glioblastoma
Corporate/ 2023-07-23
China NMPA Approves Phase III Clinical T...

HANGZHOU,Chinaand SHAOXING,China,July 22,2021-- Ascletis Pharma Inc. (HKEX code: 1672) today announces that China National Medical Products ...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release